Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
D000236:Adenoma / Q000150:complications; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D001971:Bromocriptine / Q000627:therapeutic use; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D005687:Galactorrhea / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy* / Q000209:etiology; D008090:Lisuride / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications; D011247:Pregnancy; D011388:Prolactin / Q000097:blood*
D004873:Ergolines; C004278:D-6-methyl-8-ergolin-1-ylacetic acid amide tartrate; D001971:Bromocriptine; D011388:Prolactin; D008090:Lisuride